MedTrace Logo

Risk Stratification and Heterogeneity for Organ Damage in Acute Diquat Poisoning

NCT06798142 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 193

Last updated 2025-12-05

No results posted yet for this study

Summary

This study aims to characterize the relationship between plasma diquat concentrations and organ damage risk.

Conditions

  • Toxic Encephalopathy
  • Diquat Poisoning

Interventions

PROCEDURE

extracorporeal treatment

Extracorporeal treatments included hemoperfusion (HP) and continuous veno-venous hemodiafiltration (CVVHDF).

Sponsors & Collaborators

  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2024-09-30
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06798142 on ClinicalTrials.gov